Crisaborole 2% (topical)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Crisaborole 2% (topical), covering 2026-04-09 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% in Patients With Mild to Moderate Atopic Dermatitis Over 8 Weeks [NA]